Market Movers | Winners: BNZI, OLOX, AGL | Losers: GDC, ENGN, TRDA
On Thursday, May 7, markets declined across the board, with the S&P 500 falling 0.38%, the Dow 30 falling 0.63%, and the Nasdaq 100 falling 0.12%. Although broad pressure was felt, a few stocks managed to outperform.
List of Market Winners
The following table shows the list of 10 stocks that generated the highest returns on the last trading day:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | BNZI | Banzai International | 2794.1% | 559.6% |
| 2 | OLOX | Olenox Industries | 890.2% | 122.6% |
| 3 | AGL | Agilon Health | 117.8% | 252.3% |
| 4 | ATRA | Atara Biotherapeutics | 92.8% | -45.1% |
| 5 | SOBR | Sobr Safe | 74.8% | -15.9% |
| 6 | RPGL | Republic Power | 72.9% | -99.0% |
| 7 | RXT | Rackspace Technology | 55.1% | 262.6% |
| 8 | OSG | Octave Specialty | 43.4% | -22.2% |
| 9 | FLNC | Fluence Energy | 39.9% | -4.1% |
| 10 | XMTR | Xometry | 39.2% | 32.0% |
List of Market Losers
- How Low Can Shopify Stock Go?
- Nokia (NOK) Reset: Is the Infrastructure Giant Still Undervalued At $13?
- Is Universal Health Services Stock an Under-Analyzed Capital Compounder Opportunity?
- RadNet Earnings: AI Fuels Revenue Beat And Guidance Raise
- Intel Foundry’s $1 Trillion Upside
- Where Could The Next Breakout for Insmed Stock Come From
On the other hand, the following table shows the list of 10 stocks that generated the lowest returns:
| # | Ticker | Company Name | 1-D Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | GDC | GD Culture | -87.8% | -96.5% |
| 2 | ENGN | enGene Therapeutics | -80.6% | -81.0% |
| 3 | TRDA | Entrada Therapeutics | -57.3% | -33.4% |
| 4 | SHFS | SHF | -41.4% | -56.1% |
| 5 | ARAY | Accuray | -38.6% | -64.5% |
| 6 | FSLY | Fastly | -38.2% | 91.6% |
| 7 | PLNT | Planet Fitness | -31.2% | -59.4% |
| 8 | BETR | Better Home & Finance | -28.5% | -6.3% |
| 9 | SHAK | Shake Shack | -28.3% | -14.7% |
| 10 | KALA | Kala Bio | -27.8% | -85.1% |
Why does this matter? Significant stock moves – up or down – deserve your attention. Sharp declines in fundamentally strong names can offer smart buying opportunities. And when momentum aligns with solid fundamentals, riding the trend can be highly rewarding. Among these stocks, we find Atara Biotherapeutics (ATRA) and Planet Fitness (PLNT) attractive.
Stock picking can fail no matter how good the strategy is. The Trefis High Quality Portfolio turns single-stock insights into a robust market-beating portfolio strategy.
Movers – Last One Week
Analysing over the last one week (5 trading days), the S&P 500 rising 1.78%, the Dow 30 falling 0.11%, and the Nasdaq 100 rising 4.05% ended the day with mixed results. This divergence was echoed in stock-level activity.
List of 1-Week Market Winners
The following table shows the list of 10 stocks that generated the highest returns over the last week:
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | CHRN | ChronoScale | 394636.8% | 394636.8% |
| 2 | BNZI | Banzai International | 1864.2% | 559.6% |
| 3 | OLOX | Olenox Industries | 618.6% | 122.6% |
| 4 | SOBR | Sobr Safe | 229.7% | -15.9% |
| 5 | CNSP | CNS Pharmaceuticals | 212.8% | 35.2% |
| 6 | CUE | Cue Biopharma | 142.4% | 290.0% |
| 7 | RXT | Rackspace Technology | 141.1% | 262.6% |
| 8 | AGL | Agilon Health | 117.0% | 252.3% |
| 9 | ATRA | Atara Biotherapeutics | 108.2% | -45.1% |
| 10 | FATE | Fate Therapeutics | 94.4% | 147.3% |
List of 1-Week Market Losers
Similarly, the following table shows the 10 stocks that were at the bottom in terms of returns:
| # | Ticker | Company Name | 1-W Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | GDC | GD Culture | -96.2% | -96.5% |
| 2 | ENGN | enGene Therapeutics | -76.3% | -81.0% |
| 3 | SDOT | Sadot | -65.2% | -72.0% |
| 4 | EMBC | Embecta | -60.7% | -69.3% |
| 5 | JAGX | Jaguar Health | -57.2% | -90.9% |
| 6 | XXII | 22nd Century | -54.4% | -93.8% |
| 7 | PMI | Picard Medical | -51.5% | -87.4% |
| 8 | TRDA | Entrada Therapeutics | -49.3% | -33.4% |
| 9 | CVM | CEL-SCI | -47.9% | -69.6% |
| 10 | CREG | Smart Powerr | -46.9% | -64.7% |
Movers – Last One Month
On a slightly wider timeline over the last one month, broader market witnessed strong advances in the S&P 500 rising 8.17%, the Dow 30 rising 3.52%, and the Nasdaq 100 rising 14.70%. Participation was broad, although not entirely uniform.
List of 1-Month Market Winners
The following table shows the 10 stocks that generated the maximum returns over the last one month:
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | CHRN | ChronoScale | 394636.8% | 394636.8% |
| 2 | AKAN | Akanda | 5289.9% | 261.4% |
| 3 | MSAI | MultiSensor AI | 3404.8% | -49.7% |
| 4 | CENN | Cenntro | 3108.0% | -50.9% |
| 5 | NXPL | NextPlat | 1195.0% | -86.9% |
| 6 | BNZI | Banzai International | 961.7% | 559.6% |
| 7 | OLOX | Olenox Industries | 656.1% | 122.6% |
| 8 | QNCX | Quince Therapeutics | 610.0% | -96.1% |
| 9 | KITT | Nauticus Robotics | 361.3% | 193.2% |
| 10 | CUE | Cue Biopharma | 335.0% | 290.0% |
List of 1-Month Market Losers
In the same period, these 10 stocks were at the bottom in terms of returns:
| # | Ticker | Company Name | 1-M Returns |
YTD Returns |
|---|---|---|---|---|
| 1 | CTNT | Cheetah Net Supply Chain Service | -99.1% | -99.0% |
| 2 | AREB | American Rebel | -96.5% | -100.0% |
| 3 | GDC | GD Culture | -95.1% | -96.5% |
| 4 | ASBP | Aspire Biopharma | -87.0% | -97.1% |
| 5 | NMTC | NeuroOne Medical Technologies | -82.5% | -83.4% |
| 6 | SOWG | Sow Good | -80.6% | -76.6% |
| 7 | SDOT | Sadot | -78.9% | -72.0% |
| 8 | JAGX | Jaguar Health | -78.7% | -90.9% |
| 9 | PHGE | BiomX | -78.7% | -66.9% |
| 10 | KIDZ | Classover | -78.5% | -92.5% |
Picking winners on a consistent basis is not an easy task – especially given the volatility associated with a single stock. Instead, the Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.